Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys for immunological relapse in anti-PLA2R1-positive membranous nephropathy
2023-503226-39-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jul 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in membranous glomerulonephritis (MGN), sponsored by Centre Hospitalier Universitaire de Nice. Started Jul 2023; status: completed.
02
Drugs
interferon alfa
03
Conditions
membranous glomerulonephritis (MGN)
Beyond the preview
Go deeper on 2023-503226-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503226-39-00.